Active Ingredient: NALMEFENE HYDROCHLORIDE
Proprietary Name: NALMEFENE HYDROCHLORIDE
Dosage Form; Route of Administration: SOLUTION; INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Strength: EQ 2MG BASE/2ML (EQ 1MG BASE/ML)
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AP
Application Number: A212955
Product Number: 001
Approval Date: Feb 8, 2022
Applicant Holder Full Name: PURDUE PHARMA LP
Marketing Status:
Prescription
Patent and Exclusivity Information
